Personalized Antisense Oligonucleotide Therapy for a Participant With TARDBP ALS

Clinical trial NCT07703462 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07703462
Sponsor: n-Lorem Foundation
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2026-12-01
Primary completion: 2028-12-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.